Inhibition of SIRT1 Reactivates Silenced Cancer Genes
Author Information
Author(s): Pruitt Kevin, Zinn Rebekah L, Ohm Joyce E, McGarvey Kelly M, Kang Sung-Hae L, Watkins D. Neil, Herman James G, Baylin Stephen B
Primary Institution: The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Hypothesis
Does inhibiting SIRT1 lead to the reactivation of silenced tumor suppressor genes without altering their DNA hypermethylation?
Conclusion
Inhibiting SIRT1 can reactivate silenced tumor suppressor genes while maintaining their promoter DNA hypermethylation.
Supporting Evidence
- SIRT1 was found to localize to the promoters of silenced tumor suppressor genes.
- Inhibition of SIRT1 led to increased acetylation of histones at the promoters of re-expressed genes.
- Blocking SIRT1 function caused re-expression of genes like SFRP1 and E-cadherin, which are often silenced in cancer.
- Gene reactivation occurred without changes in the DNA methylation status of the promoters.
- SIRT1 inhibition affected key phenotypic aspects of cancer cells, including reduced drug resistance.
Takeaway
Scientists found that blocking a protein called SIRT1 can wake up important genes that help stop cancer, even if those genes are still covered in a chemical that usually keeps them quiet.
Methodology
The study used RNA interference and pharmacological approaches to inhibit SIRT1 in breast and colon cancer cell lines and measured the effects on tumor suppressor gene expression.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website